Literature DB >> 20659127

Toll-like receptor (TLR)-9 genetics and function in sarcoidosis.

M Veltkamp1, C H M Van Moorsel, G T Rijkers, H J T Ruven, J M M Van Den Bosch, J C Grutters.   

Abstract

Sarcoidosis is a systemic disorder characterized by the formation of non-caseating granulomas in variable organs. Toll-like receptor (TLR)-9 is important in the innate immune response against both Mycobacterium tuberculosis and Propionibacterium acnes, candidate causative agents in sarcoidosis. The aim of our study was to investigate possible genetic and functional differences in TLR-9 between patients and controls. TLR-9 single nucleotide polymorphisms were genotyped in 533 patients and divided into a study cohort and validation cohort and 185 healthy controls. Furthermore, part of the promotor as well as the entire coding region of the TLR-9 gene were sequenced in 20 patients in order to detect new mutations. No genetic differences were found between patients and controls. In order to test TLR-9 function, peripheral blood mononuclear cells (PBMCs) of 12 healthy controls and 12 sarcoidosis patients were stimulated with a TLR-9 agonist and the induction of interleukin (IL)-6, interferon (IFN)-γ and IL-23 was measured. Sarcoidosis patients produce significantly less IFN-γ upon stimulation with different stimuli. Regarding IL-23 production, a significant difference between patients and controls was found only after stimulation with the TLR-9 agonist. In conclusion, we did not find genetic differences in the TLR-9 gene between sarcoidosis patients and controls. Sarcoidosis patients produce less IFN-γ regardless of the stimulating agent, probably reflecting the anergic state often seen in their peripheral blood T lymphocytes. The differences in TLR-9-induced IL-23 production could indicate that functional defects in the TLR-9 pathway of sarcoidosis patients play a role in disease susceptibility or evolution.
© 2010 The Authors. Clinical and Experimental Immunology © 2010 British Society for Immunology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20659127      PMCID: PMC2990931          DOI: 10.1111/j.1365-2249.2010.04205.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  36 in total

1.  High prevalence of Mycobacterium tuberculosis DNA in biopsies from sarcoidosis patients from Catalonia, Spain.

Authors:  E Fité; M T Fernández-Figueras; R Prats; M Vaquero; J Morera
Journal:  Respiration       Date:  2005-08-17       Impact factor: 3.580

2.  Toll-like receptor (TLR) 4 polymorphism Asp299Gly is not associated with disease course in Dutch sarcoidosis patients.

Authors:  M Veltkamp; J C Grutters; C H M van Moorsel; H J T Ruven; J M M van den Bosch
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

3.  Solid-phase and bead-based cytokine immunoassay: a comparison.

Authors:  Wilco de Jager; Ger T Rijkers
Journal:  Methods       Date:  2006-04       Impact factor: 3.608

4.  CARD15/NOD2, CD14, and toll-like receptor 4 gene polymorphisms in Greek patients with sarcoidosis.

Authors:  Maria Gazouli; Aimilios Koundourakis; John Ikonomopoulos; Elias J Gialafos; Aggeliki Rapti; Vassilis G Gorgoulis; Christos Kittas
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2006-03       Impact factor: 0.670

5.  Sarcoidosis and NOD1 variation with impaired recognition of intracellular Propionibacterium acnes.

Authors:  Tsuyoshi Tanabe; Ikuo Ishige; Yoshimi Suzuki; Yukie Aita; Asuka Furukawa; Yuki Ishige; Keisuke Uchida; Takashige Suzuki; Tamiko Takemura; Soichiro Ikushima; Masaru Oritsu; Tetsuji Yokoyama; Yukari Fujimoto; Koichi Fukase; Naohiro Inohara; Gabriel Nunez; Yoshinobu Eishi
Journal:  Biochim Biophys Acta       Date:  2006-07-25

6.  Serum anti-mycobacterial heat shock proteins antibodies in sarcoidosis and tuberculosis.

Authors:  Anna Dubaniewicz; Susanne Kämpfer; Mahavir Singh
Journal:  Tuberculosis (Edinb)       Date:  2005-12-13       Impact factor: 3.131

7.  Proliferative response of peripheral blood mononuclear cells and levels of antibody to recombinant protein from Propionibacterium acnes DNA expression library in Japanese patients with sarcoidosis.

Authors:  Y Ebe; S Ikushima; T Yamaguchi; K Kohno; A Azuma; K Sato; I Ishige; Y Usui; T Takemura; Y Eishi
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2000-10       Impact factor: 0.670

8.  Putative association of a TLR9 promoter polymorphism with atopic eczema.

Authors:  N Novak; C-F Yu; C Bussmann; L Maintz; W-M Peng; J Hart; T Hagemann; A Diaz-Lacava; H-J Baurecht; N Klopp; S Wagenpfeil; H Behrendt; T Bieber; J Ring; T Illig; S Weidinger
Journal:  Allergy       Date:  2007-07       Impact factor: 13.146

9.  Toll-like receptor (TLR) 4 polymorphisms are associated with a chronic course of sarcoidosis.

Authors:  S Pabst; G Baumgarten; A Stremmel; M Lennarz; P Knüfermann; A Gillissen; H Vetter; C Grohé
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

10.  TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis.

Authors:  Andre Bafica; Charles A Scanga; Carl G Feng; Cynthia Leifer; Allen Cheever; Alan Sher
Journal:  J Exp Med       Date:  2005-12-19       Impact factor: 14.307

View more
  7 in total

Review 1.  Toll like receptors in diseases of the lung.

Authors:  Melissa A Kovach; Theodore J Standiford
Journal:  Int Immunopharmacol       Date:  2011-05-30       Impact factor: 4.932

2.  Concomitant axillary mycobacteriosis and neuro-sarcoidosis: diagnostic pitfalls.

Authors:  Roderich Meckenstock; Audrey Therby; Catherine Chapelon-Abric; Chantal Nifle; Jean Paul Beressi; Constance Lebas; Alix Greder-Belan
Journal:  BMJ Case Rep       Date:  2011-09-13

Review 3.  Idiopathic giant cell myocarditis and cardiac sarcoidosis.

Authors:  Lori A Blauwet; Leslie T Cooper
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

Review 4.  Sarcoidosis vs. Sarcoid-like reactions: The Two Sides of the same Coin?

Authors:  Georgi Tchernev; Claudio Tana; Cosima Schiavone; José-Carlos Cardoso; Julian Ananiev; Uwe Wollina
Journal:  Wien Med Wochenschr       Date:  2014-03-25

Review 5.  Interleukin-12 family cytokines and sarcoidosis.

Authors:  Sabine Ringkowski; Paul S Thomas; Cristan Herbert
Journal:  Front Pharmacol       Date:  2014-10-27       Impact factor: 5.810

6.  Fungal cell wall agents and bacterial lipopolysaccharide in organic dust as possible risk factors for pulmonary sarcoidosis.

Authors:  Sanja Stopinšek; Alojz Ihan; Barbara Salobir; Marjeta Terčelj; Saša Simčič
Journal:  J Occup Med Toxicol       Date:  2016-09-21       Impact factor: 2.646

Review 7.  The Role of Propionibacterium acnes in the Pathogenesis of Sarcoidosis and Ulcerative Colitis: How This Connection May Inspire Novel Management of These Conditions.

Authors:  Sirisha Sakhamuru; Srikala Kambampati; Shehnaz Wasim; Vishal Kukkar; Bilal Haider Malik
Journal:  Cureus       Date:  2020-10-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.